The effects of message framing and healthcare provider recommendation on adult hepatitis B vaccination: A randomized controlled trail

被引:17
|
作者
Kasting, Monica L. [1 ]
Head, Katharine J. [2 ]
Cox, Dena [3 ]
Cox, Anthony D. [3 ]
Zimet, Gregory D. [4 ]
机构
[1] Purdue Univ, Dept Hlth & Kinesiol, 800 W Stadium Ave, W Lafayette, IN 47907 USA
[2] Indiana Univ Purdue Univ, Dept Commun Studies, 425 Univ Blvd, Indianapolis, IN 46202 USA
[3] Indiana Univ, Kelley Sch Business, 801 W Michigan St, Indianapolis, IN 46202 USA
[4] Indiana Univ, Sch Med, Dept Pediat, 410 W 10th St, Indianapolis, IN 46202 USA
关键词
Prospect theory; Hepatitis B virus; Hepatitis B vaccines; Vaccination; Vaccine uptake; Health communication; Patient acceptance of healthcare; Randomized controlled trial; Health promotion; Framing; HUMAN-PAPILLOMAVIRUS VACCINATION; LOSS-FRAMED MESSAGES; PERCEIVED RISK INFLUENCE; UNITED-STATES; RELATIVE PERSUASIVENESS; ADVISORY-COMMITTEE; HPV VACCINATION; PROSPECT-THEORY; COMMUNICATION; IMMUNIZATION;
D O I
10.1016/j.ypmed.2019.105798
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Many adults in the U.S. do not receive recommended vaccines, and the research literature remains inconclusive on the best communication strategies for increasing this behavior. This study examined the association of message framing (gained-framed vs. loss-framed vs. control), and healthcare provider (HCP) recommendation (offered vs. recommended) on uptake of adult hepatitis B virus (HBV) vaccination in a high risk population using a 3 x 2 block design randomized controlled trial. Fear of shots, fear of vaccines, and perceived message framing were examined in secondary analyses. Of the 1747 participants, 47.7% (n = 833) received 0 doses of HBV vaccine, 27.8% (n = 485) received 1 dose, 10.4% received 2 doses, and 14.1% received all 3 recommended doses. There was not a significant interaction between message framing and HCP recommendation (p = .59). Mean number of doses received by the gain-framed group (m = 0.96) was not significantly different from the loss-framed group (m = 0.97, RR = 0.99, 95% CI = 0.88-1.12). However, those receiving any framing message received significantly more doses (m = 0.96) than those in the control condition (m = 0.81, RR = 1.17, 95%CI = 1.06-1.31). Participants who received a HCP recommendation received significantly more vaccine doses (m = 0.95) than those in the vaccine-offered condition (mean = 0.82, RR = 1.16, 95%CI = 1.05-1.28). These results suggest there is no difference in vaccine uptake between gain-frame and loss-frame messages, but both are better than a control message. These results also support advising HCP to provide a strong recommendation for vaccinations beyond merely offering it to patients. This study has implications for vaccine uptake beyond HBV, and can inform future research on effective vaccine communication research.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Randomized controlled trial of concurrent hepatitis A and B vaccination
    Bryan, JP
    McCardle, P
    South-Paul, JE
    Fogarty, JP
    Legters, LJ
    Perine, PL
    [J]. MILITARY MEDICINE, 2001, 166 (02) : 95 - 101
  • [2] The effects of message framing on cervical cancer screening: A randomized controlled trial.
    Fujiwara, Hiroyuki
    Shimoda, Akihiro
    Ishikawa, Yoshiki
    Takei, Yuji
    Machida, Shizuo
    Taneichi, Akiyo
    Ohashi, Mai
    Takahashi, Yoshifumi
    Morisawa, Hiroyuki
    Koyanagi, Takahiro
    Saga, Yasushi
    Suzuki, Mitsuaki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Effectiveness of oral levamisole as an adjuvant to hepatitis B vaccination in healthcare workers non-responsive to previous vaccination: A randomized controlled trial
    Sayad, Babak
    Vazirian, Armin
    Bozorgomid, Arezoo
    Sayad, Nazanin
    Janbakhsh, Alireza
    Afsharian, Mandana
    Mansouri, Feizollah
    Vaziri, Siavash
    Rezaeian, Shahab
    Gholizadeh, Maryam
    [J]. NEW MICROBES AND NEW INFECTIONS, 2023, 53
  • [4] A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine
    Li, Fangjun
    Hu, Yuansheng
    Zhou, Youming
    Chen, Lixin
    Xia, Wei
    Song, Yufei
    Tan, Zhengliang
    Gao, Lidong
    Yang, Zhong
    Zeng, Gang
    Han, Xing
    Li, Junhua
    Li, Jing
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (05) : E157 - E161
  • [5] Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial
    Choi, IS
    Koh, YI
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2002, 88 (06) : 584 - 591
  • [6] Accelerated Hepatitis B Vaccination Schedule among Drug Users: A Randomized Controlled Trial
    Hwang, Lu-Yu
    Grimes, Carolyn Z.
    Tran, Thanh Quoc
    Clark, April
    Xia, Rui
    Lai, Dejian
    Troisi, Catherine
    Williams, Mark
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (10): : 1500 - 1509
  • [7] Effects of message framing and health literacy on intention to perform diabetes self-care: A randomized controlled trial
    Park, Jihyun
    Kim, Su Hyun
    Kim, Jung Guk
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 161
  • [8] Can Self-Prediction Overcome Barriers to Hepatitis B Vaccination? A Randomized Controlled Trial
    Cox, Anthony D.
    Cox, Dena
    Cyrier, Rosalie
    Graham-Dotson, Yolanda
    Zimet, Gregory D.
    [J]. HEALTH PSYCHOLOGY, 2012, 31 (01) : 97 - 105
  • [9] Recommendation of lamivudine-to-entecavir switching treatment in chronic hepatitis B responders: Randomized controlled trial
    Matsuura, Kentaro
    Tanaka, Yasuhito
    Kusakabe, Atsunori
    Hige, Shuhei
    Inoue, Jun
    Komatsu, Masashi
    Kuramitsu, Tomoyuki
    Hirano, Katsuharu
    Ohno, Tomoyoshi
    Hasegawa, Izumi
    Kobashi, Haruhiko
    Hino, Keisuke
    Hiasa, Yoichi
    Nomura, Hideyuki
    Sugauchi, Fuminaka
    Nojiri, Shunsuke
    Joh, Takashi
    Mizokami, Masashi
    [J]. HEPATOLOGY RESEARCH, 2011, 41 (06) : 505 - 511
  • [10] A Double-Blind Randomized Controlled Trial of Intradermal Hepatitis B Vaccination with Topical Imiquimod in Subjects with Occult Hepatitis B Infection
    Hung, Ivan F. N.
    Wong, Danny Ka Ho
    Seto, Wai-Kay
    Fung, James
    Yuen, Kwok-Yung
    Yuen, Man-Fung
    [J]. HEPATOLOGY, 2018, 68 : 255A - 256A